BWXT Names Nuclear Medicine Business as BWXT Medical
(LYNCHBURG, Va. – Feb. 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. (BWXT Medical), in order to better align with the company’s products, customer base and strategy. BWXT’s entry into the nuclear medicine industry began with […]
OPG and BWXT Make Significant Progress in Production of Life-Saving Medical Isotope at Darlington Nuclear Generating Station
Darlington to become first large-scale nuclear station to produce molybdenum-99 Peterborough, Ont. – Ontario Power Generation (OPG), its subsidiary Laurentis Energy Partners (Laurentis), BWXT ITG Canada Inc. and its affiliates (BWXT) are making significant progress toward the production of molybdenum-99 (Mo-99) at OPG’s Darlington Nuclear Generating Station. Mo-99 is a much-needed medical isotope used in over […]
BWXT Successfully Demonstrates Labeling of Cold Kits with its Mo-99 / Tc-99m Technology
(LYNCHBURG, Va. – Feb. 25, 2020) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully labeled technetium-99m (Tc-99m) derived from its proprietary molybdenum-99 (Mo-99) production process and its proprietary Tc-99m generators with nine of the most widely used cold kits in the North American market. As the company announced in 2018, BWXT’s […]
BWXT Completes Acquisition of Sotera Health’s Nordion Medical Isotope Business
LYNCHBURG, Va. – BWX Technologies, Inc. (NYSE:BWXT) announced today that it has completed the acquisition of Sotera Health’s Nordion medical isotope business. The acquisition adds approximately 150 highly trained and experienced personnel, two specialized production centers and a uniquely licensed infrastructure that will de-risk BWXT’s entry into the medical radioisotope market. “We are extremely pleased […]
BWXT Signs Medical Isotope Development Agreement with Bruce Power
(LYNCHBURG, Va. – July 12, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that a subsidiary has signed an agreement with Bruce Power that will enable the two companies to collaborate on the development and supply of medical isotopes. Under the terms of the agreement, the parties will identify market opportunities for medical isotopes, with […]
BWXT Selects Ontario Power Generation to Provide Irradiation Services for New Medical Isotope Manufacturing Technology
LYNCHBURG, Va. – BWX Technologies, Inc. is expanding its longstanding relationship with Ontario Power Generation (OPG), whose wholly owned subsidiary Canadian Nuclear Partners (CNP) plans to provide irradiation services to support BWXT’s new medical isotope manufacturing technology for molybdenum-99. Earlier this year, BWXT announced that it has developed an innovative and unique process to produce […]
BWXT Announces Breakthrough Medical Isotope Manufacturing Technology
BWX Technologies, Inc. (NYSE:BWXT) (“BWXT” or the “Company”) announced today that it has developed an innovative and unique process to manufacture molybdenum-99 (Mo-99) that will enable a stable, North American supply of this critical diagnostic imaging radionuclide. The Mo-99 produced will be used in newly designed technetium-99m (Tc-99m) generators that are in commercial development at […]
BWXT Announces Strategic Acquisition of Sotera Health’s Nordion Medical Isotope Business
BWX Technologies, Inc. (NYSE:BWXT) (“BWXT” or the “Company”) announced today that it has signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope business. The acquisition accelerates and de-risks BWXT’s entry into the medical radioisotope market by adding licensed infrastructure, approximately 150 highly trained and experienced personnel, and two production centers to BWXT. “Today’s […]
